. Author manuscript; available in PMC: 2018 Jan 11.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2010 Oct 25;82(1):425–434. doi: 10.1016/j.ijrobp.2010.09.004

Table 1.

Description of “Arms” analyzed in this study.

“Arm”	Description	(Prescribed) RT dose/fractionation	Prescribed BED	Chemo	Actual BED delivered [median (min-max) 25^th 75^th]
1	88-08 Arm A	60 Gy (2 Gy qd)	72	Induction Cisplatin/vinblastine	72.00 (48.00-86.40) 72.00, 72.00
2	90-15	69.6 Gy (1.2 Gy bid)	77.95	Concurrent Cisplatin/vinblastine	77.95 (40.07, 79.81) 77.46, 77.95
3	91-06	69.6 Gy (1.2 Gy bid)	77.95	Concurrent Cisplatin/etoposide	77.95 (45.77-77.95) 77.95, 77.95
4	92-04 Arm A	69.6 Gy (1.2 Gy bid)	77.95	Concurrent Cisplatin/etoposide	74.67 (47.00-81.73) 74.34, 74.67
5	92-04 Arm B	63 Gy (1.8/2 Gy qd)	74.9	Induction and concurrent Cisplatin/vinblastine	77.95 (57.79-81.71) 77.95, 77.95
6	93-09 Arm B	61 Gy (1.8/2 Gy qd)	72.3	Concurrent cisplatin/etoposide	72.28 (53.10-76.46) 72.28, 72.28
7	94-10 Arm A	63 Gy (1.8/2 Gy qd)	74.9	Induction Cisplatin/vinblastine	74.67 (42.48-77.80) 74.67, 74.67
8	94-10 Arm B	63 Gy (1.8/2 Gy qd)	74.9	Concurrent Cisplatin/vinblastine	74.67 (42.48-77.80) 74.67, 74.67
9	94-10 Arm C	69.6 Gy (1.2 Gy bid)	77.95	Concurrent Cisplatin/etoposide	77.95 (40.32-82.35) 77.95, 77.95
10	98-01 Arm A	69.6 Gy (1.2 Gy bid)	77.95	Induction and Concurrent Carboplatin/paclitaxel	77.95 (56.45-85.63) 77.95, 77.95
11	98-01 Arm B	69.6 Gy (1.2 Gy bid)	77.95	Induction and Concurrent Carboplatin/paclitaxel	77.95 (54.98-82.35) 77.95, 77.95